Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Locations section updated: added a general 'Locations' grouping and included CA, MA, NY, and TX; removed California/Massachusetts/New York/Texas locations. The footer revision changed to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.5%
    Check dated 2025-12-23T09:11:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2. The previous Revision: v3.3.1 entry has been removed.
    Difference
    0.0%
    Check dated 2025-12-01T17:50:56.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and v3.2.0 was removed on the page, reflecting a minor update to the document metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:52:38.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page. The study details and other content remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T07:16:52.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Results have been posted and key outcomes are now presented on the page. The updates include the results posting dates and outcome measures such as CBR, ORR, PFS, and OS.
    Difference
    0.4%
    Check dated 2025-11-03T01:21:29.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    1%
    Check dated 2025-10-05T10:30:01.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.